Alan F. Denenberg
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/22665_denenber_1.jpg?itok=VT0hcIWt)
Filters
Dynamics Special Purpose $601 million combination with Senti Biosciences
We are advising Dynamics, a SPAC, on the transaction
Intuit $1 billion common stock offering
The shares are listed on Nasdaq
Marathon Digital Holdings $650 million convertible senior notes offering
We advised Marathon Digital Holdings on its offering of 1% convertible notes due 2026
First Advantage $345 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Revolution Medicines $250 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
SiTime $518 million follow-on offering
The shares are listed on the Nasdaq Global Market
Cryoport $403 million notes offering and concurrent $249 million stock offering
The company issued 0.75% convertible senior notes due 2026 and sold shares in a registered direct offering
Aligos Therapeutics $75 million at-the-market offering
The company issued common stock in the SEC-registered at-the-market offering
SVB Financial $2.25 billion concurrent offerings of notes and preferred stock
The company issued senior notes due 2026 and depositary shares representing Series D and Series E perpetual preferred stock
ForgeRock $316 million IPO
We advised the underwriters on the IPO and NYSE listing